Home/Filings/4/0001144204-16-099139
4//SEC Filing

Arch Therapeutics, Inc. 4

Accession 0001144204-16-099139

CIK 0001537561operating

Filed

May 4, 8:00 PM ET

Accepted

May 5, 12:43 PM ET

Size

7.2 KB

Accession

0001144204-16-099139

Insider Transaction Report

Form 4
Period: 2016-05-03
DAVIS RICHARD E
CFO & TREASURER
Transactions
  • Award

    Common Stock

    2016-05-03+103,000103,000 total
  • Award

    Stock Option (right to buy)

    2016-05-03+150,000150,000 total
    Exercise: $0.39Exp: 2026-05-02Common Stock (150,000 underlying)
Footnotes (2)
  • [F1]Of the Shares subject to this grant, all are outside the 2013 Stock Incentive Plan (the "Plan") and 100% shall fully vest on the second anniversary of the date of grant. In addition, in the event of a Change of Control (as such term is defined in the Plan) 100% of grant will immediately vest.
  • [F2]Of the Shares subject to this Grant, 25% shall vest immediately and 1/36 of the remaining shares shall vest on each of the next thirty-six (36) monthly anniversaries of the vesting commencement date.

Issuer

Arch Therapeutics, Inc.

CIK 0001537561

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001537561

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 12:43 PM ET
Size
7.2 KB